Drug Type Chemical drugs |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization AdvanCell Isotopes Pty Ltd.Startup |
Active Organization AdvanCell Isotopes Pty Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | IN | AdvanCell Isotopes Pty Ltd.Startup | 22 Jan 2024 |
Lung Cancer | Preclinical | IN | AdvanCell Isotopes Pty Ltd.Startup | 22 Jan 2024 |